Need Help?


The Genetic Overlap between Metabolic and Psychiatric Diseases (GOMAP) study comprises samples from four patient groups: 964 schizophrenia samples, 921 type 2 diabetes patients, 582 patients with comorbid schizophrenia and type 2 diabetes and 280 samples with another psychiatric diagnosis.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00010001484 Illumina HumanCoreExome-12v1-0 2611
Publications Citations
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
BMC Psychiatry 18: 2018 249
Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.
Transl Psychiatry 8: 2018 252